GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: VincentTH who wrote (365)	4/28/1999 2:16:00 PM
From: Racso	Read Replies (2) of 410

To all: I think this stock is worth a position now. Fundamentally it is among the cheapest in the Amex Biotech Index [see comparison below] and the recent quarter release was quite positive showing promising growth in a wide range of products. Technically there is a consistent support line at 38 for the last 8 trading days. Also, the stock is trading well below its 200 DMA which in the last year only happenned back in September when it seemed the world was going to end. Net flows are quite strong today and hopefully should continue as such. Here is how GENZ compared to other member of the Amex Biotech Index: Price/Book: GENZ 2.7X vs BGEN 10.5X, AMGN 13.9X, IMNX 32.5X, CNTO 6x 99 P/E: GENZ 21.5X vs BGEN 39.5X, AMGN 37.7X, IMNX 181.8X, CNTO 55.7X Price/Sales: GENZ 4.5X, BGEN 12.5X, AMGN 12.5X, IMNX 28.9X, CNTO 7.6X I think these numbers speak for themselves. I was intrigued by the insider sales but frankly it happens and most concerns on this issue do appear to be reflected already in the stock price.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next